Haemostatic mechanisms in human placenta.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Baillière's Best Practice & Research: Clinical Haematology

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1521-6926(02)00098-1PMID 12763486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of syncytial fusion: a review.

  2002cited by this paper
• Mouse Models in Coagulation

  2002cited by this paper
• Clotting and hemorrhage in the placenta--a delicate balance.

  2002cited by this paper
• Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome

  2002cited by this paper
• Gene targeting of coagulation factors and embryogenesis

  2002cited by this paper
• Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.

  2002cited by this paper
• Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblast cell invasion.

  2002cited by this paper
• Key regulatory transcription factors involved in placental trophoblast development--a review.

  2001cited by this paper
• Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block.

  2001cited by this paper
• The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts.

  2001cited by this paper
• Villous trophoblast: morphometric perspectives on growth, differentiation, turnover and deposition of fibrin-type fibrinoid during gestation.

  2001cited by this paper
• The Placenta Dilemma

  2000cited by this paper
• Cell culture models of human trophoblast II: trophoblast cell lines--a workshop report.

  2000cited by this paper
• Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells.

  2000cited by this paper
• Expression of tissue factor pathway inhibitor in human fetal and placental tissues.

  2000cited by this paper
• Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.

  2000cited by this paper
• Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome.

  1999cited by this paper
• Thrombophilic Polymorphisms Are Common in Women with Fetal Loss without Apparent Cause

  1999cited by this paper
• Uteroplacental Hemostasis in Intrauterine Fetal Growth Retardation

  1999cited by this paper
• Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

  1999cited by this paper
• Annexin V is critical in the maintenance of murine placental integrity.

  1999cited by this paper
• Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation.

  1999cited by this paper
• The Decidua Regulates Hemostasis in Human Endometrium

  1999cited by this paper
• Case-control Study of the Frequency of Thrombophilic Disorders in Couples with Late Foetal Loss and no Thrombotic Antecedent

  1999cited by this paper
• Thrombomodulin: A New Marker for Placental Abruption

  1999cited by this paper
• Increased frequency of genetic thrombophilia in women with complications of pregnancy.

  1999cited by this paper
• Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta

  1998cited by this paper
• Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization.

  1998cited by this paper
• Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli.

  1998cited by this paper
• Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta.

  1998cited by this paper
• Gene expression of nitric oxide synthase in cultured human term placental trophoblast during in vitro differentiation.

  1998cited by this paper
• Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies.

  1998cited by this paper
• Abnormal Expression of Type 1 Plasminogen Activator Inhibitor and Tissue Factor in Severe Preeclampsia

  1998cited by this paper
• Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

  1997cited by this paper
• Placental pathology of fetal growth restriction.

  1997cited by this paper
• Factor V Leiden Is Associated with Repeated and Recurrent Unexplained Fetal Losses

  1997cited by this paper
• Classification of human placental stem villi: Review of structural and functional aspects

  1997cited by this paper
• Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

  1997cited by this paper
• Nitric Oxide Synthase Activities in Human Myometrium and Villous Trophoblast Throughout Pregnancy

  1996cited by this paper
• The fibrinoids of the human placenta: origin, composition and functional relevance.

  1996cited by this paper
• Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.

  1996cited by this paper
• Isolation and cultivation of endothelial cells derived from human placenta.

  1996cited by this paper
• Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.

  1995cited by this paper
• Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.

  1995cited by this paper
• Tissue Factor Activity of Syncytiotrophoblast Plasma Membranes and Tumoral Trophoblast Cells in Culture

  1995cited by this paper
• Implantation and the placenta: key pieces of the development puzzle.

  1994cited by this paper
• The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.

  1994cited by this paper
• Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.

  1994cited by this paper
• Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.

  1994cited by this paper
• cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

  1994cited by this paper
• Biology and Facultative Secretion of Plasminogen Activator Inhibitor-2

  1993cited by this paper
• Pathology of the Human Placenta

  1992cited by this paper
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

  1990cited by this paper
• Tissue factor: identification and characterization of cell types in human placentae.

  1990cited by this paper
• Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

  1989cited by this paper
• Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

  1987cited by this paper
• Fibrinolysis in pregnancy

  1986cited by this paper
• Cellular Localisation in Placenta of Placental Type Plasminogen Activator Inhibitor

  1986cited by this paper
• Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae.

  1986cited by this paper
• Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta

  1985cited by this paper
• Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.

  1985cited by this paper
• Tissue factor (coagulation factor III) is present in placental microvilli and cofractionates with microvilli membrane proteins.

  1985cited by this paper
• Isolation and characterization of thrombomodulin from human placenta.

  1984cited by this paper
• Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals.

  1981cited by this paper

• In Vitro Evaluation of the Impact of Oxygen Concentrations on Thrombomodulin Expression in a First-Trimester Trophoblast Cell Line.

  2025cites this paper
• Gaps in maternal-fetal interface rejection response: chronic histiocytic intervillositis

  2025cites this paper
• Sex-differentiated placental methylation and gene expression regulation has implications for neonatal traits and adult diseases

  2025cites this paper
• La placenta humana

  2025cites this paper
• Le placenta humain

  2024cites this paper
• Establishing Expectancy Values for Fibrin Monomer in Uncomplicated Pregnancy

  2024cites this paper
• Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia

  2023cites this paper
• Procoagulant Properties of Extracellular Vesicles in Normal and Pathological Pregnancy

  2023cites this paper
• Inherited thrombophilia and anticoagulant therapy for women with reproductive failure

  2020cites this paper
• Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling

  2019cites this paper
• Syncytiotrophoblast-Derived Extracellular Vesicles in Pathophysiology of Preeclampsia

  2019cites this paper
• ENDOTHELIAL DYSFUNCTION DURING PREGNANCY: PREDICTION OF THE CHILD MORBIDITY

  2019cites this paper
• Changes in thrombin activatable fibrinolysis inhibitor and its role in normal pregnancy and pre-eclampsia

  2017cites this paper
• 17 – Placental Function in Intrauterine Growth Restriction

  2017cites this paper
• The Role of Anticoagulants in the Prevention of Pregnancy Complications

  2017cites this paper
• Role of ADAMTS5 in Unexplained Fetal Growth Restriction (FGR)

  2016cites this paper
• Молекулярно-генетические аспекты фетального программирования аномальных маточных кровотечений пубертатного периода: роль синдрома эндотелиальной дисфункции

  2016cites this paper
• Microparticle source and tissue factor expression in pregnancy

  2015cites this paper
• Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature.

  2015cites this paper
• La placenta humana

  2015cites this paper
• Le placenta humain

  2015cites this paper
• Endothelial dysfunction markers in abnormal uterine bleeding in pubertal girls born with intrauterine growth retardation

  2015cites this paper
• Anatomical and Histopathologic Analysis of Placenta in Dilation and Evacuation Specimens

  2014cites this paper
• Altered decorin leads to disrupted endothelial cell function: a possible mechanism in the pathogenesis of fetal growth restriction?

  2014cites this paper
• Evaluation of Haemostatic Changes Associated with Unexplained Recurrent Early Pregnancy Loss

  2013cites this paper
• Pregnancy and Thrombophilia

  2013cites this paper
• Fibrinolytic system in preeclampsia.

  2013cites this paper
• Prediction and prevention of venous thrombosis in pregnancy

  2013cites this paper
• Neonatal outcome of the pregnancies associated with placental villous thrombosis – thrombophilic status of the mothers and the infants

  2012cites this paper
• Hemostasis in Pregnancy and Obstetric Surgery

  2012cites this paper
• Placental syndecan expression is altered in human idiopathic fetal growth restriction.

  2012cites this paper
• Low-Molecular-Weight Heparin in Women with Repeated Implantation Failure

  2011cites this paper
• Hemostasis in Pre-Eclampsia

  2011cites this paper
• Abnormal inflammation in a rat model of spontaneous fetal loss leads to maternal coagulopathies associated with placental haemostatic alterations

  2011cites this paper
• Risk factors for venous and arterial thrombosis.

  2011cites this paper
• Fertility, Infertility and Thrombophilia

  2011cites this paper
• Expresión de factor tisular, trombomodulina y PAI-1 en placentas de pacientes con restricción de crecimiento intrauterino o preeclampsia

  2011influential citation
• The Role of Proteoglycans in Contributing to Placental Thrombosis and Fetal Growth Restriction

  2011cites this paper
• Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow.

  2010influential citation
• Thrombotic risk factors: Basic pathophysiology

  2010cites this paper
• Variation in composition of the intervillous space lining in term placentas of mothers with pre-eclampsia.

  2010cites this paper
• Decorin expression is decreased in human idiopathic fetal growth restriction.

  2010influential citation
• Fausses couches spontanées et morts fœtales in utero liées à des anomalies de l’hémostase

  2010cites this paper
• Chapitre 1 – La placentation humaine

  2010cites this paper
• The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.

  2010cites this paper
• Global hemostasis in pregnancy: are we using thromboelastography to its full potential?

  2010cites this paper
• Global Hemostasis in Pregnancy: Are We Using Thromboelastography to Its Full Potential?

  2010influential citation
• The effect of severity of pre-eclampsia on the basal plate intervillous surface lining components : a confocal laser scanning microscopy study

  2009influential citation
• Placental histomorphology in unexplained foetal loss with thrombophilia.

  2009cites this paper
• Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia

  2009cites this paper
• Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts

  2009cites this paper
• Neonatal arterial ischaemic stroke: obstetric issues.

  2009cites this paper
• Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy

  2008cites this paper
• Développement du placenta humain et physiopathologie de la pré-éclampsie

  2008cites this paper
• Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?

  2007cites this paper
• IMMUNOHISTOCHEMICAL LOCALIZATION OF THROMBOMODULIN IN NORMAL AND PREECLAMPTIC HUMAN PLACENTA

  2007cites this paper
• Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications?

  2006cites this paper
• D-dímeros ELISA en el control biológico de los tratamientos con heparina de bajo peso molecular del embarazo

  2006cites this paper
• Haemostasis and pregnancy

  2006cites this paper
• Prothrombotic mechanisms in preeclampsia.

  2005cites this paper
• THE EXPRESSION OF THROMBOMODULIN, TISSUE FACTOR, TISSUE FACTOR PATHWAY INHIBITOR AND ENDOTHELIAL PROTEIN C RECEPTOR IN NORMAL AND IUGR PLACENTA

  2005cites this paper
• Elevated factor VII as a risk factor for recurrent fetal loss

  2005cites this paper
• Thrombophilia Screening in Pregnancy

  2005cites this paper
• Perinatal Arterial Stroke: Understanding Mechanisms and Outcomes

  2005cites this paper
• Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE).

  2005cites this paper
• Perinatal arterial stroke: understanding mechanisms and outcomes.

  2005cites this paper
• Hemostasis in normal pregnancy.

  2005cites this paper
• LETTERS TO THE EDITOR: Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment

  2005cites this paper
• Stroke in newborn infants.

  2004cites this paper
• Haemostatic changes in pregnancy.

  2004cites this paper